Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Solid Tumor × Valproic Acid × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Leukemia, Myeloid, Acute 10 Brain Neoplasms 8 Myelodysplastic Syndromes 7 Neoplasm Metastasis 6 Glioblastoma 6 Recurrence 5 Lymphoma 5 Glioma 5 Sarcoma 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Leukemia 4 Colorectal Neoplasms 4 Astrocytoma 4 Ovarian Neoplasms 3 Neoplasms 3 Lymphoma, Large B-Cell, Diffuse 3 Head and Neck Neoplasms 3 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Thyroid Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Neoplasms, Neuroepithelial 2 Nasopharyngeal Carcinoma 2 Mouth Neoplasms 2 Medulloblastoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Hodgkin Disease 2 Diffuse Intrinsic Pontine Glioma 2 Central Nervous System Neoplasms 2

Interventions

pembrolizumab 12 Injections 12 Paclitaxel 10 Docetaxel 9 Cisplatin 8 senaparib 7 Nivolumab 7 Capecitabine 7 Bevacizumab 7 toripalimab 6 atezolizumab 6 Irinotecan 6 Cyclophosphamide 6 tislelizumab 5 Fluorouracil 5 fludarabine 4 apatinib 4 Leucovorin 4 Ipilimumab 4 Gemcitabine 4 Fluorodeoxyglucose F18 4 spartalizumab 3 pertuzumab 3 olaparib 3 camrelizumab 3 Rifampin 3 Radiosurgery 3 Oxaliplatin 3 Midazolam 3 Itraconazole 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02446431 2015-05-18

Metronomic

Miller Children's & Women's Hospital Long Beach

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡